TABLE 2.
FA composition (mol% of total quantified FAs) of donor and mother's milk by lactation stage1
Mother's milk2 | |||||
---|---|---|---|---|---|
Donor milk (n = 54) | Colostrum (n = 18) | Transitional (n = 80) | Early-mature (n = 92) | Later-mature (n = 45) | |
Total fat, g/dL | 3.26 ± 0.13a | 3.21 ± 0.21a | 3.86 ± 0.11b | 3.78 ± 0.10b | 4.05 ± 0.14b |
10:0 | 0.31 ± 0.06a | 0.07 ± 0.08b | 0.38 ± 0.05a | 0.33 ± 0.05a | 0.32 ± 0.06a |
12:0 | 2.85 ± 0.34a | 3.08 ± 0.43a | 5.38 ± 0.26b | 4.85 ± 0.25c | 4.46 ± 0.32c |
14:0 | 4.58 ± 0.34a | 6.46 ± 0.42b | 8.30 ± 0.26d | 7.62 ± 0.25c | 7.16 ± 0.32c |
16:0 | 18.15 ± 0.31a | 22.35 ± 0.46b | 21.14 ± 0.25c | 21.14 ± 0.23c | 20.88 ± 0.32c |
18:0 | 5.14 ± 0.14a | 5.58 ± 0.20abc | 5.47 ± 0.11ab | 5.79 ± 0.10c | 5.60 ± 0.14bc |
20:0 | 0.13 ± 0.00a | 0.17 ± 0.01b | 0.16 ± 0.00bc | 0.16 ± 0.00bc | 0.16 ± 0.01bc |
21:0 | 0.13 ± 0.01a | 0.08 ± 0.00b | 0.08 ± 0.01b | 0.09 ± 0.01b | 0.08 ± 0.01b |
22:0 | 0.05 ± 0.00a | 0.08 ± 0.01b | 0.07 ± 0.00bc | 0.07 ± 0.00bc | 0.06 ± 0.00c |
23:0 | 0.10 ± 0.01a | 0.12 ± 0.01ab | 0.13 ± 0.01b | 0.13 ± 0.01bc | 0.11 ± 0.01ac |
24:0 | 0.04 ± 0.00a | 0.12 ± 0.01b | 0.09 ± 0.00c | 0.07 ± 0.00d | 0.06 ± 0.00e |
Total SFAs | 31.86 ± 0.74a | 39.22 ± 0.97b | 41.68 ± 0.57c | 40.83 ± 0.55bc | 39.39 ± 0.71bc |
14:1n–5 | 0.21 ± 0.01a | 0.14 ± 0.02b | 0.18 ± 0.01b | 0.19 ± 0.01ac | 0.18 ± 0.01bc |
16:1n–7 | 2.64 ± 0.08a | 2.17 ± 0.10bc | 2.15 ± 0.06c | 2.28 ± 0.06b | 2.32 ± 0.08b |
17:1n–7 | 0.19 ± 0.01a | 0.17 ± 0.01bc | 0.16 ± 0.00c | 0.17 ± 0.00b | 0.17 ± 0.01bc |
18:1n–7 | 1.89 ± 0.04ac | 2.15 ± 0.06b | 1.99 ± 0.03c | 1.88 ± 0.03a | 1.91 ± 0.04ac |
18:1n–9 | 39.78 ± 0.55a | 34.95 ± 0.74bc | 33.86 ± 0.43b | 34.17 ± 0.41b | 35.20 ± 0.54c |
20:1n–9 | 0.47 ± 0.01a | 0.67 ± 0.02b | 0.59 ± 0.01c | 0.51 ± 0.01d | 0.49 ± 0.02ad |
22:1n–9 | 0.06 ± 0.00a | 0.15 ± 0.01b | 0.11 ± 0.00c | 0.08 ± 0.00d | 0.07 ± 0.00e |
24:1n–9 | 0.02 ± 0.00a | 0.18 ± 0.01b | 0.12 ± 0.00c | 0.07 ± 0.00d | 0.05 ± 0.00e |
Total MUFAs | 46.02 ± 0.58a | 41.16 ± 0.78bc | 40.03 ± 0.45b | 40.23 ± 0.43b | 41.33 ± 0.57c |
18:3n–3 (ALA) | 2.20 ± 0.07a | 1.71 ± 0.10bcd | 1.65 ± 0.06d | 1.77 ± 0.05b | 1.94 ± 0.07c |
20:3n–3 | 0.05 ± 0.00a | 0.14 ± 0.01b | 0.11 ± 0.00c | 0.09 ± 0.00d | 0.08 ± 0.00e |
20:5n–3 (EPA) | 0.14 ± 0.01a | 0.08 ± 0.01b | 0.09 ± 0.01b | 0.09 ± 0.01b | 0.08 ± 0.01b |
22:5n–3 (DPA) | 0.21 ± 0.01a | 0.26 ± 0.01b | 0.20 ± 0.01c | 0.19 ± 0.01c | 0.18 ± 0.01c |
22:6n–3 | 0.30 ± 0.22ad | 0.45 ± 0.03b | 0.40 ± 0.02c | 0.34 ± 0.16a | 0.28 ± 0.20d |
Total n–3 PUFAs | 2.87 ± 0.09a | 2.61 ± 0.13ab | 2.41 ± 0.71b | 2.43 ± 0.07b | 2.59 ± 0.09b |
18:2n–6 | 18.30 ± 0.42a | 15.30 ± 0.57b | 14.50 ± 0.33bc | 15.47 ± 0.31ad | 16.05 ± 0.41ad |
18:3n–6 | 0.15 ± 0.01a | 0.07 ± 0.01b | 0.08 ± 0.01bc | 0.11 ± 0.01d | 0.11 ± 0.01d |
20:2n–6 | 0.27 ± 0.01a | 0.67 ± 0.02b | 0.53 ± 0.01c | 0.44 ± 0.01d | 0.38 ± 0.02e |
20:3n–6 (DGLA) | 0.40 ± 0.02a | 0.69 ± 0.04b | 0.58 ± 0.02c | 0.51 ± 0.02d | 0.43 ± 0.03ae |
20:4n–6 | 0.61 ± 0.02ac | 0.71 ± 0.03b | 0.66 ± 0.02ab | 0.57 ± 0.02c | 0.51 ± 0.02d |
22:4n–6 | 0.23 ± 0.02a | 0.33 ± 0.03b | 0.22 ± 0.02a | 0.19 ± 0.02a | 0.16 ± 0.02c |
22:5n–6 | 0.03 ± 0.00a | 0.09 ± 0.01b | 0.07 ± 0.00c | 0.04 ± 0.03d | 0.04 ± 0.00ae |
Total n–6 PUFAs | 20.09 ± 0.43a | 17.98 ± 0.60b | 16.82 ± 0.34c | 17.43 ± 0.32cd | 17.79 ± 0.43d |
n–6:n–3 PUFA | 7.76 ± 0.53 | 7.07 ± 0.87 | 7.34 ± 0.42 | 7.88 ± 0.40 | 7.19 ± 0.57 |
ARA:DHA | 2.26 ± 0.09a | 1.76 ± 0.09b | 1.77 ± 0.68b | 1.87 ± 0.07bc | 2.05 ± 0.08ac |
Values are means ± SEs. With the exception of total fat (g/dL), all values are percentage composition (mol%). Associations were analyzed using PROC MIXED followed by LSMEANS for pairwise comparisons, accounting for repeated measures using an autoregressive correlation structure. a–eStatistically significant differences, P < 0.05. ALA, α-linolenic acid; ARA, arachidonic acid; DGLA, dihomo-γ-linolenic acid; DPA, docosapentaenoic acid; FA, fatty acid.
Colostrum was collected on postpartum days 1–4, transitional milk on days 8–14, early-mature milk on days 15–40, and later-mature milk at >40 d. The earliest sample available for each participant during each stage was selected for analysis.